Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 350730, 15 pages
http://dx.doi.org/10.1155/2015/350730
Review Article

Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis

1Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
2Department of Integrative Oncology, Benxi Central Hospital of China Medical University, Benxi, Liaoning 11700, China
3Postgraduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

Received 6 June 2015; Revised 3 October 2015; Accepted 13 October 2015

Academic Editor: Zhao-Xiang Bian

Copyright © 2015 Bin Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Hao and W. Q. Chen, Chinese Cancer Registry Annual Report, Military Medical Science Press, Beijing, China, 2012.
  4. D. P. Ryan, T. S. Hong, and N. Bardeesy, “Pancreatic adenocarcinoma,” The New England Journal of Medicine, vol. 371, no. 11, pp. 1039–1049, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Y. Mian, A. N. Ram, R. Tuli, and J. M. Herman, “Management options in locally advanced pancreatic cancer,” Current Oncology Reports, vol. 16, pp. 388–400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. Fung, S. Takayama, H. Ishiguro, T. Sakata, S. Adachi, and T. Morizane, “Chemotherapy for advanced or metastatic pancreatic cancer: analysis of 43 randomized trials in 3 decades (1974–2002),” Gan to Kagaku Ryoho, vol. 30, no. 8, pp. 1101–1111, 2003. View at Google Scholar · View at Scopus
  7. V. Heinemann, S. Boeck, A. Hinke, R. Labianca, and C. Louvet, “Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer,” BMC Cancer, vol. 8, pp. 82–93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. D. Von Hoff, T. Ervin, F. P. Arena et al., “Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine,” The New England Journal of Medicine, vol. 369, no. 18, pp. 1691–1703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Sun, “The role of Chinese medicine in clinical oncology,” Chinese Journal of Integrative Medicine, vol. 20, no. 1, pp. 3–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Schröder, S. Lee, T. Efferth, and Y. Motoo, “Acupuncture and herbal medicine for cancer patients,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 313751, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. W. R. Xu, G. W. Yang, Y. M. Xu et al., “The possibility of traditional chinese medicine as maintenance therapy for advanced nonsmall cell lung cancer,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 278917, 9 pages, 2014. View at Publisher · View at Google Scholar
  12. S. G. Li, H. Y. Chen, C. S. Ou-Yang et al., “The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis,” PLoS ONE, vol. 8, no. 2, Article ID e57604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Wu, J. J. Dugoua, O. Eyawo, and E. J. Mills, “Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis,” Journal of Experimental and Clinical Cancer Research, vol. 28, article 112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Z. Lu, X. T. Cao, and L. L. Wang, “Meta-analysis of middle-advanced pancreatic carcinoma treated with traditional Chinese medicine,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 29, pp. 441–443, 2014. View at Google Scholar
  15. D. Moher, B. Pham, A. Jones et al., “Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?” The Lancet, vol. 352, no. 9128, pp. 609–613, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Zintzaras and J. P. A. Ioannidis, “Heterogeneity testing in meta-analysis of genome searches,” Genetic Epidemiology, vol. 28, no. 2, pp. 123–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Yusuf, R. Peto, J. Lewis, R. Collins, and P. Sleight, “Beta blockade during and after myocardial infarction: an overview of the randomized trials,” Progress in Cardiovascular Diseases, vol. 27, no. 5, pp. 335–371, 1985. View at Publisher · View at Google Scholar · View at Scopus
  18. C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088–1101, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Gansauge, M. Ramadani, J. Pressmar et al., “NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial,” Langenbeck's Archives of Surgery, vol. 386, no. 8, pp. 570–574, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Q. Meng, C. R. Garrett, Y. H. Shen et al., “Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas,” British Journal of Cancer, vol. 107, no. 3, pp. 411–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Y. Zhu, Z. Q. Meng, L. T. Xu et al., “The therapeutic effects of Qing Re Hua Ji (QRHJ) decoction combined with HAI/TACE treating advanced pancreatic cancer: a randomized, control clinical study,” China Oncology, vol. 23, pp. 218–223, 2013. View at Google Scholar
  22. T. D. Tian, F. Yang, and J. G. Tang, “Evaluation of therapeutic effect for chemotherapy combined with Chinese herbs with the effect of heat-clearing and detoxicating as well as promoting blood circulation by removing blood stasion on advanced pancreatic cancer,” Chinese Journal of Medicine, vol. 14, pp. 428–430, 2012. View at Google Scholar
  23. N. Lu, H. Shi, J. Dong, and G. J. Shi, “Clinical observation on Shenqi Fuzheng injection combined with chemotherapy for 27 advanced pancreatic cancer patients with qi deficiency syndrome,” Journal of Traditional Chinese Medicine, vol. 55, pp. 1038–1040, 2014. View at Google Scholar
  24. Y. Zhang, Y. J. Jia, Y. Y. Sun, and J. Chen, “Xihuang pill unites gemcitabine on the clinical benefit in advanced pancreatic carcinoma,” Chinese Traditional Patent Medicine, vol. 32, pp. 13–15, 2010. View at Google Scholar
  25. J. L. You and X. X. Yao, “Clinical effect of Fuzheng Hewei formula in combination of GEMOX regimen for forty patients with advanced pancreatic,” Liaoning Journal of Traditional Chinese Medicine, vol. 36, pp. 2135–2138, 2009. View at Google Scholar
  26. H. Q. Dong, “Clinical effect of traditional Chinese medicine combined with western medicine for middle and advanced pancreatic cancer,” The Practical Journal of Cancer, vol. 29, pp. 1318–1321, 2014. View at Google Scholar
  27. Y. X. Li, “Clinical observation on treating advanced pancreatic cancer with Chansu injection plus the concurrent chemoradiotherapy,” Clinical Journal of Chinese Medicine, vol. 6, pp. 10–12, 2014. View at Google Scholar
  28. D. Wei, Y. Tan, H. Y. Liu, X. M. Su, and J. J. Peng, “Effect observation of Chinese herbal medicine of Ar Jiao for myelosuppression on 21 patients with advanced pancreatic cancer after chemotherapy,” Chinese Journal of Integrative Medicine, vol. 26, pp. 659–660, 2006. View at Google Scholar
  29. Q. J. Li, L. L. Ru, and G. W. Chen, “Effect of Fuzheng Kangai formula for 51 patients with advanced pancreatic cancer,” China Medical Herald, vol. 6, pp. 75–78, 2009. View at Google Scholar
  30. L. S. Chen, “Effect observation of compound Kushen injection in combination of radiotherapy for pancreatic cancer,” Zhejiang Journal of Traditional Chinese Medicine, vol. 47, article 800, 2012. View at Google Scholar
  31. L. L. Dai, “Evaluation of efficacy of Jiedu Huayu Tongfu granule on advanced pancreatic cancer patients with damp-heat and stasis-toxic syndrome,” Journal of Tianjin University of Traditional Chinese Medicine, vol. 33, pp. 270–273, 2014. View at Google Scholar
  32. Y. L. Zhang, Effect of composite Kushen injections combined stereotactic gamma knife treatment of locally advanced pancreatic cancer [M.S. thesis], Shanxi Medical University, Taiyuan, China, 2012.
  33. X. F. Liu, P. Z. Shang, F. Y. Li, and S. Q. Wang, “Effect of qi replenishing and blood circulation activating drugs on radiotherapy and chemotherapy for moderate and advanced pancreatic cancer,” Journal of Southeast University (Medical Science Edition), vol. 33, pp. 5–8, 2014. View at Google Scholar
  34. Q. Zhu, J. B. Kang, Q. Lie, J. G. Li, and W. J. Qi, “Kanglaite injection combined with γ-ray stereotactic body radiation therapy for 28 cases with locally advanced pancreatic cancer,” China Cancer, vol. 22, pp. 931–934, 2013. View at Google Scholar
  35. C. P. Shan, X. Q. Yang, W. Cui, and H. Z. Guo, “Clinical observation of Kanglaite injection combined with low-dose chemotherapy for advanced pancreatic cancer,” Traditional Chinese Drug Research & Clinical Pharmacology, vol. 18, pp. 72–73, 2007. View at Google Scholar
  36. Y. Q. Ni, J. L. You, S. X. Gong et al., “The role of improving quality of life of WD-3 alone or combined with chemotherapy for patients with advanced pancreatic cancer,” Jiangsu Journal of Traditional Chinese Medicine, vol. 45, pp. 29–31, 2013. View at Google Scholar
  37. S. C. Ma, D. Zhao, X. M. Hou, and F. Yuan, “Combination treatment with gemcitabine chemotherapy and Kanglaite injection on advanced pancreatic cancer,” Modern Oncology, vol. 20, pp. 1415–1417, 2012. View at Google Scholar
  38. D. Han, C. Li, G. W. Yang et al., “Treatment of smoothing the liver and regulating the spleen combined with hyperthermia and intra-arterial infusion chemotherapy for advanced pancreatic cancer,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, pp. 254–257, 2012. View at Google Scholar
  39. Y. H. Shen, L. M. Liu, X. Y. Zhu et al., “A clinical trial on the effect of Qingyi Huaji herbal decoction combined with transcatheter arterial chemotherapy and radiotherapy for inoperable pancreatic cancer,” Journal of Traditional Chinese Medicine, vol. 51, pp. 1093–1100, 2010. View at Google Scholar
  40. H. Q. Zhang, S. J. Li, Q. Z. Qiao, and W. L. Zhao, “The Chinese herbal formula Qinre Huaji decoction treating advanced pancreatic cancer: a randomized, control trial,” Chinese Remedies & Clinics, vol. 10, pp. 1415–1416, 2010. View at Google Scholar
  41. P. M. Wang, Y. L. Zhu, H. L. Zhang, P. Ji, S. Y. Li, and Y. P. Lv, “Clinical study of Kangai injection combined with stereotactic radiotherapy for advanced pancreatic cancer,” Guide of China Medicine, vol. 11, pp. 296–297, 2013. View at Google Scholar
  42. S. M. Suo and X. H. Suo, “The role of qi replenishing and blood circulation activating drugs on radiotherapy and chemotherapy for pancreatic cancer,” Journal of Qiqihar Medical College, vol. 30, article 953, 2009. View at Google Scholar
  43. B. Yang, C. W. Liang, Y. Pan, S. F. Cai, J. X. Du, and D. X. Peng, “Clinical observation of Yanshu injection combined with chemotherapy of advanced pancreatic carcinoma,” Liaoning Journal of Traditional Chinese Medicine, vol. 41, pp. 1926–1927, 2014. View at Google Scholar
  44. L. J. Yin, G. H. Zhao, T. G. Ding, Z. X. Peng, and X. F. Hou, “Clinical observation of Jinlong capsule combined with whole body gamma knife for advanced pancreatic cancer,” Chinese Journal of Clinical Oncology, vol. 31, pp. 1129–1131, 2004. View at Google Scholar
  45. B. S. Wang, X. F. Liu, Z. Q. Wu et al., “The effect role of qi replenishing and blood circulation activating drugs on radiotherapy and chemotherapy for advanced pancreatic cancer,” Chinese Journal of Integrative Medicine, vol. 20, pp. 736–738, 2000. View at Google Scholar
  46. X. D. Chen, Q. L. Liang, X. Y. Li et al., “Effect of composite salviae dropping pill combined with chemotherapy in 41 cases with pancreatic carcinoma,” Journal of Oncology, vol. 11, pp. 46–48, 2005. View at Google Scholar
  47. L. H. Dou, “Effect of Kangai injection combined with GP regimen for local advanced pancreatic,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 16, pp. 207–209, 2010. View at Google Scholar
  48. M. H. Levy, M. D. Adolph, A. Back et al., “Palliative care,” Journal of the National Comprehensive Cancer Network, vol. 10, pp. 1284–1309, 2012. View at Google Scholar
  49. T. J. Smith, S. Temin, E. R. Alesi et al., “American Society of Clinical Oncology Provisional Clinical Opinion: the integration of palliative care into standard oncology care,” Journal of Clinical Oncology, vol. 30, no. 8, pp. 880–887, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. The Chinese Society of Clinical Oncology Pancreatic Cancer Expert Committee, “Chinese consensus on pancreatic cancer diagnosis and treatment (2014 version),” Chinese Clinical Oncology, vol. 19, pp. 358–370, 2014. View at Google Scholar
  51. J.-H. Yin, W.-D. Shi, X.-Y. Zhu, Z. Chen, and L.-M. Liu, “Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF,” Integrative Cancer Therapies, vol. 11, no. 1, pp. 37–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. Y.-Q. Hua, Z. Chen, Z.-Q. Meng et al., “High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway,” Oncology Letters, vol. 8, no. 1, pp. 17–24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Zhang, P. Wang, H. Q. Ouyang et al., “Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer,” PLoS ONE, vol. 8, no. 7, Article ID e70334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. M. W. Saif, F. Lansigan, S. Ruta et al., “Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies,” Phytomedicine, vol. 17, no. 3-4, pp. 161–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. M. W. Saif, J. Li, L. Lamb et al., “First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer,” Cancer Chemotherapy and Pharmacology, vol. 73, no. 2, pp. 373–380, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. T.-G. Liu, Y. Huang, D.-D. Cui et al., “Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice,” BMC Cancer, vol. 9, article 250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. S. M. Kim, S. Y. Lee, D. Y. Yuk et al., “Inhibition of NF-κB by Ginsenoside Rg3 enhances the susceptibility of colon cancer cells to Docetaxel,” Archives of Pharmacal Research, vol. 32, no. 5, pp. 755–765, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Jin, B. Yixi, L. Waikei et al., “Immunoregulatory and anti-tumor effects of Polysaccharopeptide and Astragalus polysaccharides on tumor-bearing mice,” Immunopharmacology and Immunotoxicology, vol. 30, no. 4, pp. 771–782, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Y. Liu, Y. J. Zhu, T. Zhang et al., “Anti-tumor effects of atractylenolide I isolated from atractylodes macrocephala in human lung carcinoma cell lines,” Molecules, vol. 18, no. 11, pp. 13357–13368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Niu and Q.-X. Meng, “Chemical and preclinical studies on Hedyotis diffusa with anticancer potential,” Journal of Asian Natural Products Research, vol. 15, no. 5, pp. 550–565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. Z.-J. Zhang, Y.-K. Yang, and W.-Z. Wu, “Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice,” Journal of Translational Medicine, vol. 12, pp. 57–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. Q. Cai, J. Lin, L. Wei et al., “Hedyotis diffusa Willd inhibits colorectal cancer growth in vivo via inhibition of STAT3 signaling pathway,” International Journal of Molecular Sciences, vol. 13, no. 5, pp. 6117–6128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. J. M. Lin, Q. Y. Li, H. W. Chen, H. Lin, Z. J. Lai, and J. Peng, “Hedyotis diffusa willd. extract suppresses proliferation and induces apoptosis via IL-6-inducible STAT3 pathway inactivation in human colorectal cancer cells,” Oncology Letters, vol. 9, no. 4, pp. 1962–1970, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. E. P. Hu, D. G. Wang, J. Y. Chen, and X. L. Tao, “Novel cyclotides from Hedyotis diffusa induce apoptosis and inhibit proliferation and migration of prostate cancer cells,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 3, pp. 4059–4065, 2015. View at Google Scholar
  65. Z. Liu, M. Liu, M. Liu, and J. Li, “Methylanthraquinone from Hedyotis diffusa WILLD induces Ca2+-mediated apoptosis in human breast cancer cells,” Toxicology in Vitro, vol. 24, no. 1, pp. 142–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Liu, W. Zhang, X.-J. Wang, and S. Liu, “Antitumor effect of Kanglaite injection in human pancreatic cancer xenografts,” BMC Complementary and Alternative Medicine, vol. 14, pp. 228–234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. H. L. Xu, X. Zhao, X. H. Liu, P. X. Xu, K. M. Zhang, and X. K. Lin, “Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway,” Drug Design, Development and Therapy, vol. 9, pp. 2735–2744, 2015. View at Publisher · View at Google Scholar